Trading-company supplier based in Shanghai, China, tracked by the GLP-1 Forum community at CAUTION. Assigned to manufacturer cluster Group 2, meaning its finished kits come from the same upstream fill-and-finish line as the other vendors in that cluster. Group 2. 236 Finnrick samples. MOQ 300 vials. Domestic USA 3-5 days.
Shanghai Nexa Pharma (Nexaph) is based in Shanghai, China, specialising in GLP-1 Peptides, Research Peptides, minimum order MOQ 300 vials.
No manufacturing licence is recorded for Shanghai Nexa Pharma (Nexaph) in our data. That is an absence of information rather than evidence of a problem, but it means nothing here has been verified against a regulator's register.
No independent assay in our records names Shanghai Nexa Pharma (Nexaph) as the manufacturer. Manufacturer attribution only appears where a certificate of analysis records it, so this is common and is not a quality signal in itself.
Manufacturer entries describe who produces a compound, not who sells it to you. For purchasing, the vendor directory records storefront reachability, assay history and FDA warning-letter history separately.
Directories: All manufacturers, Vendor directory, Independent lab tests.